SCHEMBL7166332

SCHEMBL7166332

N[C@@H](CCCN1CCCCC1)C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.55
MAPK1 P28482 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
DPP7 Q9UHL4 1/20 0.50
GSR P00390 2/20 0.48
L3MBTL1 Q9Y468 1/20 0.47
HRH3 Q9Y5N1 1/20 0.46
ARG1 P05089 4/20 0.44
ARG2 P78540 4/20 0.44
MAPT P10636 2/20 0.44
ALDH1A1 P00352 1/20 0.44
POLB P06746 1/20 0.44
GLA P06280 1/20 0.43
TSHR P16473 1/20 0.43
NFKB1 P19838 1/20 0.43
APEX1 P27695 1/20 0.43
CYP2C19 P33261 1/20 0.43
NOS2 P35228 1/20 0.43
DDAH1 O94760 2/20 0.42
GRM8 O00222 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL266522 1.00 CYP1A2 (0.55) CYP1A2MAPK1SMN1; SMN2DPP7GSR
SCHEMBL23099381 1.00 CYP1A2 (0.55) CYP1A2MAPK1SMN1; SMN2DPP7GSR
SCHEMBL25660549 0.98 CYP1A2 (0.52) CYP1A2MAPK1SMN1; SMN2DPP7GSR
SCHEMBL24642331 0.94 CYP1A2 (0.53) CYP1A2MAPK1SMN1; SMN2DPP7GSR
Hydrochloric Acid SCHEMBL23013062 0.93 CYP1A2 (0.52) CYP1A2MAPK1SMN1; SMN2DPP7GSR
Hydrochloric Acid SCHEMBL23013673 0.93 CYP1A2 (0.52) CYP1A2MAPK1SMN1; SMN2DPP7GSR
SCHEMBL26792957 0.92 GSR (0.53) CYP1A2MAPK1SMN1; SMN2DPP7GSR
Trifluoroacetic Acid SCHEMBL6429122 0.90 CYP1A2 (0.46) CYP1A2MAPK1SMN1; SMN2DPP7GSR
SCHEMBL31369810 0.89 GSR (0.53) CYP1A2MAPK1SMN1; SMN2DPP7GSR
SCHEMBL1527303 0.88 DPP7 (0.53) CYP1A2MAPK1SMN1; SMN2DPP7GSR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9493402-B2 Omega-aminoalkylamides of R-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells DOMPÉ FARMACEUTICI S.P.A. (IT) 2016-11-15 US disclosed
EP-1366018-B1 OMEGA-AMINOALKYLAMIDES OF (R)-2-ARYL-PROPIONIC ACIDS AS INHIBITORS OF THE CHEMOTAXIS OF POLYMORPHONUCLEATE AND MONONUCLEATE CELLS DOMPÉ FARMACEUTICI S P A (IT) 2016-07-06 EP disclosed
US-20130079514-A1 \"OMEGA-AMINOALKYLAMIDES OF R-2-ARYL-PROPIONIC ACIDS AS INHIBITORS OF THE CHEMOTAXIS OF POLYMORPHONUCLEATE AND MONONUCLEATE CELLS\ Dompé S.p.A. (IT) 2013-03-28 US disclosed
EP-1366018-A1 OMEGA-AMINOALKYLAMIDES OF R-2-ARYL-PROPIONIC ACIDS AS INHIBITORS OF THE CHEMOTAXIS OF POLYMORPHONUCLEATE AND MONONUCLEATE CELLS Dompé S.P.A. (IT) 2003-12-03 EP disclosed
WO-2002068377-A1 OMEGA-AMINOALKYLAMIDES OF R-2-ARYL-PROPIONIC ACIDS AS INHIBITORS OF THE CHEMOTAXIS OF POLYMORPHONUCLEATE AND MONONUCLEATE CELLS Dompé S.p.A. (IT) 2002-09-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130079514-A1 \"OMEGA-AMINOALKYLAMIDES OF R-2-ARYL-PROPIONIC ACIDS AS INHIBITORS OF THE CHEMOTAXIS OF POLYMORPHONUCLEATE AND MONONUCLEATE CELLS\ C5AR2, C3AR1, C5AR1 CYP1A2 317/4885MAPK1 1816/4885SMN1; SMN2 3737/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.